X-Chem, Excelra: partnership to accelerate drug discovery
Analytics company Excelra and artificial intelligence specialist X-Chem are joining forces to accelerate preclinical drug discovery and help researchers find new drug candidates for hard-to-drug targets. The collaboration will center on Excelra’s GOSTAR and X-Chem’s RosalindAI technologies.
X-Chem senior vice president Noor Shaker said, “AI is revolutionizing drug discovery in ways never thought possible before, and RosalindAI is leading the way with AI tools that are accurate, scalable, and robust, enabling a transformation in preclinical drug discovery. Our collaboration with Excelra will enable us to leverage GOSTAR data and enable AI in ways never possible before.”
